TRDA
Entrada Therapeutics Inc
NASDAQ: TRDA · HEALTHCARE · BIOTECHNOLOGY
$7.32
-0.90% today
Updated 2026-06-03
Market cap
$243.41M
P/E ratio
—
P/S ratio
42.42x
EPS (TTM)
$-4.00
Dividend yield
—
52W range
$5 – $16
Volume
0.4M
Entrada Therapeutics Inc (TRDA) Insider transactions
Net insider activity
Net buying (759,785 shares)
Buy transactions
41
Sell transactions
59
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-01 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 2,500 | $12.95 | $32375.00 |
| 2026-03-10 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 11,388 | $13.02 | $148215.96 |
| 2026-03-10 | DOWDEN, NATHAN J | President & COO | Sale | 11,894 | $13.05 | $155188.15 |
| 2026-03-09 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 5,089 | $13.00 | $66162.60 |
| 2026-03-09 | DOWDEN, NATHAN J | President & COO | Sale | 3,116 | $13.02 | $40582.78 |
| 2026-03-04 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 7,988 | $12.25 | $97892.14 |
| 2026-03-03 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 5,712 | $11.76 | $67152.56 |
| 2026-03-03 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 7,577 | $11.76 | $89078.24 |
| 2026-03-03 | DOWDEN, NATHAN J | President & COO | Sale | 14,038 | $11.76 | $165036.34 |
| 2026-03-03 | DOSHI, DIPAL | Director, CEO | Sale | 19,181 | $11.76 | $225499.51 |
| 2026-03-02 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 2,939 | $11.66 | $34262.57 |
| 2026-03-02 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 3,898 | $11.66 | $45442.49 |
| 2026-03-02 | DOWDEN, NATHAN J | President & COO | Sale | 7,223 | $11.66 | $84205.01 |
| 2026-03-02 | DOSHI, DIPAL | Director, CEO | Sale | 9,869 | $11.66 | $115051.82 |
| 2026-03-01 | WENTWORTH, KORY JAMES | Chief Financial Officer | Buy | 66,600 | — | — |
| 2026-03-01 | WENTWORTH, KORY JAMES | Chief Financial Officer | Buy | 44,600 | — | — |
| 2026-03-01 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Buy | 83,200 | — | — |
| 2026-03-01 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Buy | 55,800 | — | — |
| 2026-03-01 | DOWDEN, NATHAN J | President & COO | Buy | 83,200 | — | — |
| 2026-03-01 | DOWDEN, NATHAN J | President & COO | Buy | 55,800 | — | — |
| 2026-03-01 | DOSHI, DIPAL | Director, CEO | Buy | 208,000 | — | — |
| 2026-03-01 | DOSHI, DIPAL | Director, CEO | Buy | 139,400 | — | — |
| 2025-11-21 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 8,910 | $9.98 | $88931.60 |
| 2025-11-20 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 13,386 | $9.07 | $121394.96 |
| 2025-11-20 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 13,082 | $9.07 | $118690.37 |
| 2025-11-20 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 1,213 | $9.07 | $11000.45 |
| 2025-11-20 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 1,186 | $9.07 | $10760.34 |
| 2025-11-14 | PARMAR, KUSH | Director, 10% Owner | Sale | 200,000 | $8.80 | $1.76M |
| 2025-11-14 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 200,000 | $8.80 | $1.76M |
| 2025-11-12 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 80,881 | $7.73 | $625331.45 |
| 2025-11-12 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 11,494 | $7.95 | $91431.32 |
| 2025-11-12 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 7,321 | $7.73 | $56602.31 |
| 2025-11-12 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 1,040 | $7.95 | $8272.89 |
| 2025-11-11 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 30,879 | $7.54 | $232812.22 |
| 2025-11-11 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 11,701 | $7.39 | $86480.92 |
| 2025-11-11 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 2,795 | $7.54 | $21072.90 |
| 2025-11-11 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 1,059 | $7.39 | $7826.96 |
| 2025-11-10 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 25,364 | $7.21 | $182973.36 |
| 2025-11-10 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 2,947 | $7.22 | $21290.31 |
| 2025-11-10 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 2,296 | $7.21 | $16563.11 |
| 2025-11-10 | BAKER, BROS. ADVISORS LP | 10% Owner | Buy | 267 | $7.22 | $1928.91 |
| 2025-09-02 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 1,734 | $5.43 | $9415.97 |
| 2025-09-02 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 1,760 | $5.43 | $9557.15 |
| 2025-09-02 | DOWDEN, NATHAN J | President & COO | Sale | 1,746 | $5.43 | $9481.13 |
| 2025-09-02 | DOSHI, DIPAL | Director, CEO | Sale | 8,723 | $5.43 | $47367.63 |
| 2025-07-09 | PARMAR, KUSH | Director, 10% Owner | Sale | 20,065 | $7.50 | $150527.63 |
| 2025-07-09 | PARMAR, KUSH | Director, 10% Owner | Sale | 6,935 | $7.50 | $52026.37 |
| 2025-07-09 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 20,065 | $7.50 | $150527.63 |
| 2025-07-09 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 6,935 | $7.50 | $52026.37 |
| 2025-07-01 | PARMAR, KUSH | Director, 10% Owner | Sale | 18,578 | $7.12 | $132323.66 |
| 2025-07-01 | PARMAR, KUSH | Director, 10% Owner | Sale | 6,422 | $7.12 | $45741.34 |
| 2025-07-01 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 18,578 | $7.12 | $132323.66 |
| 2025-07-01 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 6,422 | $7.12 | $45741.34 |
| 2025-06-30 | PARMAR, KUSH | Director, 10% Owner | Sale | 18,578 | $6.81 | $126566.34 |
| 2025-06-30 | PARMAR, KUSH | Director, 10% Owner | Sale | 6,422 | $6.81 | $43751.16 |
| 2025-06-30 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 18,578 | $6.81 | $126566.34 |
| 2025-06-30 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 6,422 | $6.81 | $43751.16 |
| 2025-06-27 | PARMAR, KUSH | Director, 10% Owner | Sale | 55,735 | $6.91 | $385128.85 |
| 2025-06-27 | PARMAR, KUSH | Director, 10% Owner | Sale | 19,265 | $6.91 | $133121.15 |
| 2025-06-27 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 55,735 | $6.91 | $385128.85 |
| 2025-06-27 | 5AM, VENTURES V, L.P. | 10% Owner | Sale | 19,265 | $6.91 | $133121.15 |
| 2025-06-11 | ZEIHER, BERNHARDT G | Director | Buy | 19,000 | — | — |
| 2025-06-11 | THISTLE, MARY | Director | Buy | 19,000 | — | — |
| 2025-06-11 | PARMAR, KUSH | Director, 10% Owner | Buy | 19,000 | — | — |
| 2025-06-11 | KIM, PETER S | Director | Buy | 19,000 | — | — |
| 2025-06-11 | CHAPMAN, GINA | Director | Buy | 19,000 | — | — |
| 2025-06-01 | RADHAKRISHNAN, MAHA | Director | Buy | 38,000 | — | — |
| 2025-04-03 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 11,134 | — | — |
| 2025-04-03 | WENTWORTH, KORY JAMES | Chief Financial Officer | Buy | 11,134 | $2.10 | $23381.40 |
| 2025-03-17 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 1,784 | $10.67 | $19035.28 |
| 2025-03-03 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 4,929 | $11.68 | $57563.82 |
| 2025-03-03 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 6,138 | $11.68 | $71683.25 |
| 2025-03-03 | DOWDEN, NATHAN J | President & COO | Sale | 5,144 | $11.68 | $60074.72 |
| 2025-03-03 | DOSHI, DIPAL | Director, CEO | Sale | 17,566 | $11.68 | $205146.29 |
| 2025-03-01 | WENTWORTH, KORY JAMES | Chief Financial Officer | Buy | 63,300 | — | — |
| 2025-03-01 | WENTWORTH, KORY JAMES | Chief Financial Officer | Buy | 42,400 | — | — |
| 2025-03-01 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Buy | 90,800 | — | — |
| 2025-03-01 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Buy | 60,800 | — | — |
| 2025-03-01 | DOWDEN, NATHAN J | President & COO | Buy | 90,800 | — | — |
| 2025-03-01 | DOWDEN, NATHAN J | President & COO | Buy | 60,800 | — | — |
| 2025-03-01 | DOSHI, DIPAL | Director, CEO | Buy | 173,400 | — | — |
| 2025-03-01 | DOSHI, DIPAL | Director, CEO | Buy | 116,200 | — | — |
| 2024-12-11 | MPM, BIOVENTURES 2018, L.P. | 10% Owner | Sale | 21,787 | $20.23 | $440751.01 |
| 2024-12-11 | MPM, BIOVENTURES 2014, L.P. | 10% Owner | Sale | 21,787 | $20.23 | $440751.01 |
| 2024-12-10 | MPM, BIOVENTURES 2018, L.P. | 10% Owner | Sale | 22,935 | $20.77 | $476359.95 |
| 2024-12-10 | MPM, BIOVENTURES 2014, L.P. | 10% Owner | Sale | 22,935 | $20.77 | $476359.95 |
| 2024-12-03 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 11,703 | $20.15 | $235786.19 |
| 2024-12-02 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 5,000 | — | — |
| 2024-12-02 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 5,000 | $20.00 | $99978.00 |
| 2024-12-02 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 4,088 | $20.26 | $82833.51 |
| 2024-11-29 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 1,000 | — | — |
| 2024-11-29 | WENTWORTH, KORY JAMES | Chief Financial Officer | Buy | 1,000 | $2.10 | $2100.00 |
| 2024-11-29 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 100 | $20.00 | $2000.00 |
| 2024-11-13 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 2,700 | $20.04 | $54108.81 |
| 2024-11-11 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 6,000 | — | — |
| 2024-11-11 | WENTWORTH, KORY JAMES | Chief Financial Officer | Sale | 8,637 | $19.98 | $172562.08 |
| 2024-11-11 | WENTWORTH, KORY JAMES | Chief Financial Officer | Buy | 6,000 | $2.10 | $12600.00 |
| 2024-11-11 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 1,409 | $20.01 | $28191.13 |
| 2024-11-06 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 9,554 | $18.71 | $178752.47 |
| 2024-11-06 | SETHURAMAN, NATARAJAN | President, Research & Develop. | Sale | 2,745 | $19.32 | $53023.52 |
Frequently asked questions
Are TRDA insiders buying or selling?
Over the transactions on record, TRDA insiders have been net sellers, with about $10.34M in stock sold across 59 sales, against 19 open-market purchases.
Does insider selling at TRDA mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which TRDA insiders are selling the most?
Recent selling is concentrated in a few names. PARMAR, KUSH accounts for the largest share on record, with about $2.83M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.